Members are currently creating their profile

About the company

Type
Company

Members type
innovator

Headquarters
2300 La Chaux-de-Fonds, Suisse

Company size
1

Founders
Paulo Martins

Founded
2011

SDG's

  • Industry, innovation and infrastructure

  • Sustainable cities and communities


Social

Website
swisscustomwatches.com

Alliance member

Vitruvian Shield- Swiss Custom Watches SA

VITRUVIAN SHIELD - BIOMETRIC SWISS MADE WATCH. MEDICAL & ID WEARABLE DEVICE TO BE USED AS MAIN HUMAN & IOMT INTERFACE.

VITRUVIAN SHIELD - BIOMETRIC SWISS MADE WATCH. MEDICAL & ID WEARABLE DEVICE TO BE USED AS HUMAN & IOMT INTERFACE. IOMT= (Internet of Medical Things) DEVICE+SOFTWARE+CLOUD+VIRTUAL ID WITH BLOCKCHAIN TECHNOLOGY.

Offer

VITRUVIAN SHIELD

Description
VITRUVIAN SHIELD - BIOMETRIC SWISS MADE WATCH. MEDICAL & ID WEARABLE DEVICE TO BE USED AS MAIN HUMAN & IOMT INTERFACE.

BENEFITS & EXCLUSIVITY USER CASE 1 - HUMAN & HEALTH CARE INTERFACE USE AS MAIN INTERFACE WITH HEALTH CARE PROVIDERS IT ALLOWS TO: SHARE BIOMETRICS WITH HEALTH CARE PROVIDERS FOR 1st DIAGNOSE, TREATMENT AND RECOVERY OF MENTAL & PHYSICAL ISSUES. DETECT PATHOLOGIC INCIDENTS AND ACCIDENTS EVENTS AND CONTACT HEALTH CARE SERVICES. IDENTIFY USER ID AND MAIN IMPORTANT USEFUL HEALTH DATA TO URGENT MEDICAL ASSISTANCE. IMPROVE HEALTH AND WELLBEING. USER CASE 2 - HUMAN & VEHICLE INTERFACE USE AS MAIN INTERFACE WITH FUTURE AUTONOMOUS VEHICLES IT WILL: INFORM DRIVER WHEN BIOMETRICS ARE EXCESSIVE TO DRIVE AND VEHICLE WILL ASSIST IF NEEDED. ACTIVATES THE AUTONOMOUS EMERGENCY FEATURES IF DRIVER FEEL UNWELL. DETECTS FATIGUE & DROWSINESS EVENTS WHEN DRIVING. CALL AND SEND BIOMETRICS FOR HEALTH CARE SERVICES IN AN ACCIDENT EVENT.

Categories of application
Industrial processes, Freight transportation, Urban and inter-urban mobility

Sector of application
Supply chain efficiency, Road transport, New vehicle types, System integration, Traffic and route management, Route optimization, Sensors and monitoring, Public transport, Private transport, System integration, Behavior management

Status
R&D